The Thriving Apixaban Market: A Comprehensive Analysis of Growth and Opportunities
Apixaban , marketed under the brand name Eliquis, has emerged as one of the most significant players in the global anticoagulant market. As healthcare systems worldwide grapple with rising cardiovascular disease rates and an aging population, this innovative blood thinner has positioned itself at the forefront of modern therapeutic interventions. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=14927&type=requestsample Market Size and Growth Trajectory The apixaban market demonstrates remarkable expansion potential, though market size estimates vary across research firms. In 2024, the Eliquis (Apixaban) market generated revenue of US$ 20.1 billion, with a declining CAGR of 4.6%, and is projected to reach US$ 31.5 billion by 2034, according to recent market analysis. However, other studies suggest different growth patterns, with global Apixaban market size estimated at USD 12.58 Billion in 2024 and expected to reach USD 18.91 Billion by 2033 at a 5.2...